Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure

European Heart Journal

Volumn 23, Issue 1, 2002, Pages 59-69

  Braunschweig, Frieder ^a   Linde, C ^a   Eriksson, M J ^a   Hofman Bang, C ^a   Ryden L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ambulatory; Congestive heart failure; Haemodynamic monitoring; Loop diuretics; Therapy

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; DIURETIC AGENT; FUROSEMIDE; LOOP DIURETIC AGENT;

ADULT; AGED; ARTICLE; BODY WEIGHT; CASE REPORT; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEMODYNAMIC MONITORING; HUMAN; IMPLANT; LUNG ARTERY PRESSURE; MALE; PRIORITY JOURNAL; PULSE PRESSURE; QUALITY OF LIFE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; DIURETICS; ECHOCARDIOGRAPHY, DOPPLER; EQUIPMENT SAFETY; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NATRIURETIC PEPTIDE, BRAIN; QUALITY OF LIFE; VENTRICULAR FUNCTION, RIGHT; WITHHOLDING TREATMENT;

EID: 0036401347     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2690     Document Type: Article

References (27)

1. Ohlsson A, Bennett T, Nordlander R, Rydén J, Astrom H, Rydén L. Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transducer. J Card Fail 1995; 1: 161-8.
2. Ohlsson A, Nordlander R, Bennett T et al. Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J 1998; 19: 174-84.
3. Steinhaus DM, Lemery R, Bresnahan DR, Jr. et al. Initial experience with an implantable hemodynamic monitor. Circulation 1996; 93: 745-52.
4. Ohlsson Å, Kubo SH, Steinhaus D et al. Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable hemodynamic monitor: Results of a one year multicenter feasibility study. Eur Heart J; in press.
5. Young JB, Weiner DH, Yusuf S et al. Patterns of medication use in patients with heart failure: A report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD). South Med J 1995; 88: 514-23.
6. Stewart RB, Moore MT, May FE, Marks RG, Hale WE. A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epidemiol 1991; 44: 1353-9.
7. Chrischilles EA, Foley DJ, Wallace RB et al. Use of medications by persons 65 and over: Data from the established populations for epidemiologic studies of the elderly. J Gerontol 1992; 47: M137-44.
8. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987; 57: 17-22.
9. Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet 1998; 352 (Suppl 1): S119-28.
10. Grinstead WC, Francis MJ, Marks GF, Tawa CB, Zoghbi WA, Young JB. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 73: 881-6.
11. Bennett T, Sharma A, Sutton R, Camm AJ, Erickson M, Beck R. Development of a rate adaptive pacemaker based on the maximum rate-of-rise of right ventricular pressure (RV dP/dtmax). PACE 1992; 15: 219-34.
12. Reynolds DW, Bartelt N, Taepke R, Bennett TD. Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol 1995; 25: 1176-82.
13. Chuang PP, Wilson RF, Homans DC et al. Measurement of pulmonary artery diastolic pressure from a right ventricular pressure transducer in patients with heart failure. J Card Fail 1996; 2: 41-6.
14. Rector TS, Kubo SH, Cohn JH. Patients self-assessment of their heart failure: Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987: 198-209.
15. Lipkin DP, Scriven AJ, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) 1986; 292: 653-5.
16. Zugck C, Kruger C, Durr S et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 2000; 21: 540-9.
17. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
18. Hammarstrom E, Wranne B, Pinto FJ, Puryear J, Popp RL. Tricuspid annular motion. J Am Soc Echocardiogr 1991; 4: 131-9.
19. Skjaerpe T, Hegrenaes L, Hatle L. Noninvasive estimation of valve area in patients with aortic stenosis by Doppler ultrasound and two-dimensional echocardiography. Circulation 1985; 72: 810-8.
20. Oh JK, Seward JB, Tajik AJ. Assessment of diastolic function. The Echo Manual, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins, 1999: 45-57.
21. Walma EP, Hoes AW, van Dooren C, Prins A, van der Does E. Withdrawal of long-term diuretic medication in elderly patients: A double blind randomised trial. BMJ 1997; 315: 464-8.
22. Anand IS, Veall N, Kalra GS et al. Treatment of heart failure with diuretics: Body compartments, renal function and plasma hormones. Eur Heart J 1989; 10: 445-50.
23. Yoshimura M, Yasue H, Okumura K et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87: 464-9.
24. Arakawa N, Nakamura M, Aoki H, Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996; 27: 1656-61.
25. Wallen T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart 1997; 77: 264-7.
26. Murdoch DR, McDonagh TA, Byrne J et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 1999; 138: 1126-32.
27. Johansson K, Dahlström U, Karlberg K-E, Karlsson E, Nyquist, Nylander E. The value of repeated echocardiographic evaluation in patients with idiopathic dilated cardiomyopathy during treatment with metoprolol or captopril. Scand Cardiovasc J 2000; 34: 293-300.